Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method
碩士 === 臺北醫學大學 === 藥學研究所 === 98 === Diabetic nephropathy (DN) is a complication of diabetes mellitus which may lead to end-stage renal disease. Throughout its early course, DN has no symptoms. The first laboratory abnormality is a positive sign by microalbuminuria test. However, at this stage, a kidn...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/74321667674778863473 |
id |
ndltd-TW-098TMC05551020 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-098TMC055510202016-04-22T04:23:30Z http://ndltd.ncl.edu.tw/handle/74321667674778863473 Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method 大鼠腎臟中糖尿病相關蛋白之蛋白質體之螢光高效能液相層析串聯質譜分析 Pei-Yun Tsai 蔡佩芸 碩士 臺北醫學大學 藥學研究所 98 Diabetic nephropathy (DN) is a complication of diabetes mellitus which may lead to end-stage renal disease. Throughout its early course, DN has no symptoms. The first laboratory abnormality is a positive sign by microalbuminuria test. However, at this stage, a kidney biopsy clearly shows DN. Therefore, this study is designed to establish a new method to identify the differential expression of proteins in the kidney of control and streptozotocin (STZ)-induced diabetic rats in order to discover specific indicators for early diagnosis of DN. The Spregue-Dawley rats were sacrificed at 1, 4, 12, 24 weeks after i.p. injection of sodium citrate buffer or STZ. A thiol-specific fluorogenic reagent, 4-[2-(dimethylamino)ethyl]-7-chloro-2,1,3-benzoxadiazole-4-sulfonamide (DAABD-Cl) was utilized for the derivatization of proteins and then the derivatives were quantified and collected by high performance lipid chromatography with fluorescence detection (FD-HPLC). The isolated derivatives will be further identified by liquid chromatography tandem mass spectrometry (LC-MS/MS) with the MASCOT database searching system. After 1 week of injection, the expressions of approximately 7 proteins significantly changed. Only one protein had significantly changed after 4 weeks of injection. However, after 12 weeks of treatment, the number of altered proteins rose to 9. In addition, the changes appeared before the increase of microalbumin in the urine. The results may serve to find new biomarkers to improve early detection and new drug development in diabetic-related nephropathy. 李仁愛 2010 學位論文 ; thesis 70 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 臺北醫學大學 === 藥學研究所 === 98 === Diabetic nephropathy (DN) is a complication of diabetes mellitus which may lead to end-stage renal disease. Throughout its early course, DN has no symptoms. The first laboratory abnormality is a positive sign by microalbuminuria test. However, at this stage, a kidney biopsy clearly shows DN. Therefore, this study is designed to establish a new method to identify the differential expression of proteins in the kidney of control and streptozotocin (STZ)-induced diabetic rats in order to discover specific indicators for early diagnosis of DN. The Spregue-Dawley rats were sacrificed at 1, 4, 12, 24 weeks after i.p. injection of sodium citrate buffer or STZ. A thiol-specific fluorogenic reagent, 4-[2-(dimethylamino)ethyl]-7-chloro-2,1,3-benzoxadiazole-4-sulfonamide (DAABD-Cl) was utilized for the derivatization of proteins and then the derivatives were quantified and collected by high performance lipid chromatography with fluorescence detection (FD-HPLC). The isolated derivatives will be further identified by liquid chromatography tandem mass spectrometry (LC-MS/MS) with the MASCOT database searching system. After 1 week of injection, the expressions of approximately 7 proteins significantly changed. Only one protein had significantly changed after 4 weeks of injection. However, after 12 weeks of treatment, the number of altered proteins rose to 9. In addition, the changes appeared before the increase of microalbumin in the urine. The results may serve to find new biomarkers to improve early detection and new drug development in diabetic-related nephropathy.
|
author2 |
李仁愛 |
author_facet |
李仁愛 Pei-Yun Tsai 蔡佩芸 |
author |
Pei-Yun Tsai 蔡佩芸 |
spellingShingle |
Pei-Yun Tsai 蔡佩芸 Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method |
author_sort |
Pei-Yun Tsai |
title |
Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method |
title_short |
Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method |
title_full |
Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method |
title_fullStr |
Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method |
title_full_unstemmed |
Proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (FD-LC-MS/MS) method |
title_sort |
proteome analysis of diabetic-related proteins in rat kidney by fluorogenic derivatization–liquid chromatography–tandem mass spectrometry (fd-lc-ms/ms) method |
publishDate |
2010 |
url |
http://ndltd.ncl.edu.tw/handle/74321667674778863473 |
work_keys_str_mv |
AT peiyuntsai proteomeanalysisofdiabeticrelatedproteinsinratkidneybyfluorogenicderivatizationliquidchromatographytandemmassspectrometryfdlcmsmsmethod AT càipèiyún proteomeanalysisofdiabeticrelatedproteinsinratkidneybyfluorogenicderivatizationliquidchromatographytandemmassspectrometryfdlcmsmsmethod AT peiyuntsai dàshǔshènzàngzhōngtángniàobìngxiāngguāndànbáizhīdànbáizhìtǐzhīyíngguānggāoxiàonéngyèxiāngcéngxīchuànliánzhìpǔfēnxī AT càipèiyún dàshǔshènzàngzhōngtángniàobìngxiāngguāndànbáizhīdànbáizhìtǐzhīyíngguānggāoxiàonéngyèxiāngcéngxīchuànliánzhìpǔfēnxī |
_version_ |
1718230733197148160 |